PGDM1400LS

BIOLOGICAL4 trials

Sponsors

Henry M. Jackson Foundation for the Advancement of Military Medicine, HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

ARTAcute HIV InfectionHIVHIV InfectionsHIV-1-infectionPLWH

Phase 1

Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission

WithdrawnNCT05769569

Henry M. Jackson Foundation for the Advancement of Military MedicineHIV-1-infection

Start: 2023-09-01End: 2025-07-01Updated: 2024-05-03

Evaluating the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibodies in Healthy Participants

SuspendedNCT05959707

HIV Vaccine Trials NetworkHIV Infections

Start: 2024-08-14End: 2025-01-14Target: 77Updated: 2024-07-05

RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV

RecruitingNCT06484335

Henry M. Jackson Foundation for the Advancement of Military MedicineAcute HIV Infection, ART, HIV Infections +1

Start: 2025-03-27End: 2027-08-01Target: 48Updated: 2025-09-16

The Tatelo Plus Study

RecruitingNCT06508749

National Institute of Allergy and Infectious Diseases (NIAID)HIV, HIV Infections

Start: 2024-11-11End: 2028-04-21Target: 41Updated: 2025-06-10